We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

21 hedge funds and large institutions have $1.24M invested in Tenax Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

31% more funds holding

Funds holding: 16 → 21 (+5)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

23% less capital invested

Capital invested by funds: $1.6M → $1.24M (-$363K)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$92.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$19.3K
3
Millennium Management
Millennium Management
New York
+$16.9K
4
VF
Virtu Financial
New York
+$5.22K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.82K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$46.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$22K
3
Citigroup
Citigroup
New York
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
1
Gofen & Glossberg
Illinois
$649K – – –
AC
2
Armistice Capital
New York
$334K +$92.7K +231 +23%
BlackRock
3
BlackRock
New York
$81K – – –
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
$34K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$30K -$46.1K -115 -51%
State Street
6
State Street
Massachusetts
$24K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$24K +$19.3K +48 +117%
Millennium Management
8
Millennium Management
New York
$13K +$16.9K +42 +600%
FWP
9
FAS Wealth Partners
Kansas
$10K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$8K – – –
Northern Trust
11
Northern Trust
Illinois
$6K – – –
TSS
12
Two Sigma Securities
New York
$4K +$803 +2 +17%
VF
13
Virtu Financial
New York
$4K +$5.22K +13 New
CAN
14
Cetera Advisor Networks
California
$3K +$4.01K +10 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$3K +$4.82K +12 New
TRCT
16
Tower Research Capital (TRC)
New York
$2K – – –
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$2K +$2.41K +6 New
E
18
Ergoteles
New York
$2K +$3.61K +9 New
Morgan Stanley
19
Morgan Stanley
New York
$2K +$3.61K +9 New
HF
20
HRT Financial
New York
$2K +$4.41K +11 New
Citadel Advisors
21
Citadel Advisors
Florida
– -$22K -46 Closed
Citigroup
22
Citigroup
New York
– -$4K -8 Closed

TENX Hedge Fund Activity: Q3 2022 in Review

21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2022, worth a combined $1.24M — down 23% from $1.6M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TENX positions and 2 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $92.7K. The largest seller was Vanguard Group, cutting an estimated $46.1K.

  • 21 institutional investors held Tenax Therapeutics (TENX) as of Q3 2022, up from 16 in Q2 2022.
  • Funds reported $1.24M of Tenax Therapeutics stock for Q3 2022, down 23% quarter-over-quarter.
  • 7 funds opened new Tenax Therapeutics positions in Q3 2022 and 2 closed out, a net change of +5 holders.
  • The largest Tenax Therapeutics buyer in Q3 2022 was Armistice Capital, an estimated $92.7K added.
  • The largest Tenax Therapeutics seller in Q3 2022 was Vanguard Group, an estimated $46.1K sold.

Based on aggregated 13F filings for Q3 2022.